Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01660373
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Registry
-
NCT01660373
-
- Other papers using this trial's data
- Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01660373. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
- Acronym
- TE-CLOT
- Condition
- Non-ST Segment Elevation Acute Coronary Syndrome
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Pusan National University Yangsan Hospital
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct01660373- Content hash
0d971a0e81010980c8c3ec984fb68ac236e47ad5849d102164be2135dcca09b6